Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

Presentation TVT 2019

V-Wave for HFrEF and HFpEF

Presenter: Josep Rodés-Cabau

June 15, 2019

Presentation TVT 2019

AltaValve: Attributes, Challenges, and Future Programs

Presenter: Josep Rodés-Cabau

June 14, 2019

Presentation TVT 2019

LAA Closure Technology: Current Standards and “Hot” Newcomers

Presenter: Josep Rodés-Cabau

June 14, 2019

Presentation TVT 2019

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Presenter: Josep Rodés-Cabau

June 13, 2019

Presentation TVT 2016

Conduction Disturbances and Arrhythmias After TAVR: Remaining Issues and Best Clinical Practices

Presenter: Josep Rodés-Cabau

June 17, 2016

Presentation TVT 2016

Sapien TMVR in MAC

Presenter: Josep Rodés-Cabau

June 17, 2016

Presentation TVT 2016

The Management of Severe AS With a Small Aortic Annulus

Presenter: Josep Rodés-Cabau

June 17, 2016

Presentation TVT 2016

Fortis: Design Highlights and Clinical Update

Presenter: Josep Rodés-Cabau

June 16, 2016

Presentation TVT 2015

Edwards Transcatheter Approach to Tricuspid Regurgitation (The Device and Procedure)

Presenter: Francesco Maisano, John G. Webb, Josep Rodés-Cabau

June 05, 2015

Presentation TVT 2015

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Josep Rodés-Cabau

June 05, 2015

Presentation TVT 2013

Canada

Presenter: Josep Rodes-Cabau

June 14, 2013

Presentation TVT 2013

Coronary Occlusion After TAVR: Review of a Multicenter Experience

Presenter: Josep Rodes-Cabau

June 13, 2013

Presentation TVT 2013

Concerns from Canada

Presenter: Josep Rodes-Cabau

June 13, 2013

Presentation TVT 2013

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

Presenter: Josep Rodes-Cabau

June 12, 2013

Presentation TVT 2012

The Canadian TAVR Registry

Presenter: Josep Rodes-Cabau

June 05, 2012

Presentation TVT 2012

The Amplatzer Cardiac Plug Clinical Studies Program: Perspectives, New Insights, and Future Directions

Presenter: Josep Rodes-Cabau

June 05, 2012

Presentation TVT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Josep Rodes-Cabau

June 04, 2012

Presentation TVT 2012

Design and Function/Clinical Outcomes - Sapien 3

Presenter: Josep Rodes-Cabau

June 03, 2012

Advertisement

More Support for Single Antiplatelet Therapy After TAVI

V-Wave for HFrEF and HFpEF

AltaValve: Attributes, Challenges, and Future Programs

LAA Closure Technology: Current Standards and “Hot” Newcomers

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Conduction Disturbances and Arrhythmias After TAVR: Remaining Issues and Best Clinical Practices

Sapien TMVR in MAC

The Management of Severe AS With a Small Aortic Annulus

Fortis: Design Highlights and Clinical Update

Edwards Transcatheter Approach to Tricuspid Regurgitation (The Device and Procedure)

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Canada

Coronary Occlusion After TAVR: Review of a Multicenter Experience

Concerns from Canada

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

The Canadian TAVR Registry

The Amplatzer Cardiac Plug Clinical Studies Program: Perspectives, New Insights, and Future Directions

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Design and Function/Clinical Outcomes - Sapien 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content